PBSV Pharma-Bio Serv, Inc.

OTC
$0.50

Pharma-Bio Serv, Inc. (PBSV) is expected to report earnings on December 14, 2026, after the market close. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +21.9% since its last earnings release on September 14, 2026.

Pharma-Bio Serv Missed Consensus Estimates
Monday, September 14, 2026 · 5:20 PM ET
Earnings Date
4th Quarter, Oct 2026
Dec 14
Monday · 5:20 PM ET
Earnings Whisper
-
vs $0.03
Rev est $2.7M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.41

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pharma-Bio Serv, Inc.

Pharma-bio Serv Inc is a compliance and technology transfer services consulting firm. It provides microbiological testing services & chemical testing services and related consulting services.

Sector

Business Services

Industry

Management Services

Charts powered in part by Lightweight Charts™ by TradingView.